ANAVEX LIFE SCIENCES CORP.

AVXL

{{popupValue}}
{{popupSubtitle}}

Identification

Click on a field for details on how to access that data via Web API, Excel, or CSV Download.

Ticker
AVXL
CIK0001314052
SIC2836
SectorManufacturing
Industry CategoryPharmaceutical Products
Industry GroupBiological Products, Except Diagnostic Substances

Contact

Address630 5TH AVENUE, 20TH FLOOR, NEW YORK, NY, 10111
Website anavex.com
Phone844-689-3939
CEOChristopher U. Missling
Employees40

Access This Data

Our team will help you customize a package that meets the needs of your business.

Request a Consultation

Standardized Financials

docs

Intrinio provides professional-grade historical financial data. This data is standardized, cleansed and verified to ensure the highest quality data sourced directly from the XBRL financial statements. The primary purpose of standardized financials are to facilitate comparability across a single company’s fundamentals and across all companies fundamentals.

For example, it is possible to compare total revenues between two companies as of a certain point in time, or within a single company across multiple time periods. This is not possible using the as reported financial statements because of the inherent complexity of reporting standards.

Below is a preview of several data points from each financial statement, as well as a sample of our many calculated metrics:

Income Statement
RevenueN/A
Pre-Tax Income$-47.14 million
Net Income$-47.14 million
Net Income to Common$-47.14 million
EPS$-0.55
View All
Balance Sheet
Cash$115.77 million
Assets$117.14 million
Liabilities$17.38 million
Common Equity$99.76 million
Liabilities & Equity$117.14 million
View All
Cash Flow Statement
Calculations
NOPAT$-38.49 million
EBITDA$-55.04 million
Price to EarningsN/A
Price to Book$9.30
ROE-40.17%
View All

Latest News

docs

Intrinio provides up-to-date news articles on every US company from various sources. Here are several examples:

Are You Looking for a Top Momentum Pick? Why Anavex Life Sciences (AVXL) is a Great Choice

Does Anavex Life Sciences (AVXL) have what it takes to be a top stock pick for momentum investors? Let's find out.

Article Link

Are Medical Stocks Lagging Adaptive Biotechnologies (ADPT) This Year?

Here is how Adaptive Biotechnologies (ADPT) and Anavex Life Sciences (AVXL) have performed compared to their sector so far this year.

Article Link

High Growth Tech Stocks To Watch In The US June 2025

As the U.S. market rebounds from recent declines, driven by geopolitical tensions and fluctuating oil prices, major indices like the Dow Jones and Nasdaq have shown resilience with notable gains. In this dynamic environment, identifying high growth tech stocks involves looking for companies that can capitalize on technological advancements and maintain robust performance despite external pressures such as international conflicts or economic uncertainties.

Article Link

We're Not Worried About Anavex Life Sciences' (NASDAQ:AVXL) Cash Burn

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

Article Link

Anavex Life Sciences Corp.'s (NASDAQ:AVXL) largest shareholders are individual investors with 60% ownership, institutions own 37%

Key Insights The considerable ownership by individual investors in Anavex Life Sciences indicates that they...

Article Link